Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-12 09:04 am Purchase | 2025-03-31 | 13G | CIDARA THERAPEUTICS INC NE CDTX | Adage Capital Management, L.P. | 990,000 9.040% | 990,000![]() (New Position) | Filing History |
| 2025-05-12 09:03 am Purchase | 2025-03-31 | 13G | ENSYSCE BIOSCIENCES INC PA ENSC | Adage Capital Management, L.P. | 74,711 5.320% | 74,711![]() (New Position) | Filing History |
| 2025-05-12 09:03 am Purchase | 2025-03-31 | 13G | CENTESSA PHARMACEUTICALS PLC S CNTA | Adage Capital Management, L.P. | 6,954,000 5.220% | 6,954,000![]() (New Position) | Filing History |
| 2025-05-12 09:02 am Purchase | 2025-03-31 | 13G | TRAWS PHARMA, INC PAR TRAW | Adage Capital Management, L.P. | 330,000 6.500% | 330,000![]() (New Position) | Filing History |
| 2025-05-12 09:02 am Sale | 2025-03-31 | 13G | UROGEN PHARMA LTD URGN | Adage Capital Management, L.P. | 1,277,000 2.770% | -1,651,086![]() (-56.39%) | Filing History |
| 2025-05-12 09:02 am Purchase | 2025-03-31 | 13G | AEVA TECHNOLOGIES INC AEVA | Adage Capital Management, L.P. | 1,401,454 2.560% | 1,401,454![]() (New Position) | Filing History |
| 2025-05-12 09:01 am Sale | 2025-03-31 | 13G | PROTARA THERAPEUTICS INC TARA | Adage Capital Management, L.P. | 0 0.000% | -2,250,000![]() (Position Closed) | Filing History |
| 2025-05-12 09:01 am Purchase | 2025-03-31 | 13G | MEREO BIOPHARMA GROUP PLC ADR MREO | Adage Capital Management, L.P. | 8,503,780 1.070% | 8,503,780![]() (New Position) | Filing History |
| 2025-05-12 09:00 am Sale | 2025-03-31 | 13G | LEXEO THERAPEUTICS INC LXEO | Adage Capital Management, L.P. | 237,953 0.700% | -1,971,662![]() (-89.23%) | Filing History |
| 2025-05-12 09:00 am Purchase | 2025-03-31 | 13G | ABEONA THERAPEUTICS INC NE ABEO | Adage Capital Management, L.P. | 4,411,572 8.780% | 201,143![]() (+4.78%) | Filing History |
| 2025-02-12 09:46 am Purchase | 2024-12-31 | 13G | PROQR THERAPEUTICS N.V. PRQR | Adage Capital Management, L.P. | 9,602,280 9.300% | 9,602,280![]() (New Position) | Filing History |
| 2025-02-12 09:45 am Purchase | 2024-12-31 | 13G | MONOPAR THERAPEUTICS INC MNPR | Adage Capital Management, L.P. | 599,195 9.860% | 599,195![]() (New Position) | Filing History |
| 2025-02-12 09:44 am Sale | 2024-12-31 | 13G | IMMUNIC INC IMUX | Adage Capital Management, L.P. | 139,860 1.550% | -419,581![]() (-75.00%) | Filing History |
| 2025-02-12 09:36 am Purchase | 2024-12-31 | 13G | KARYOPHARM THERAPEUTICS INC KPTI | Adage Capital Management, L.P. | 436,737 5.180% | 436,737![]() (New Position) | Filing History |
| 2025-02-12 09:35 am Sale | 2024-12-31 | 13G | ENGENE HLDGS INC ENGN | Adage Capital Management, L.P. | 1,528,768 3.000% | -801,000![]() (-34.38%) | Filing History |
| 2025-02-12 09:35 am Sale | 2024-12-31 | 13G | LEXEO THERAPEUTICS INC LXEO | Adage Capital Management, L.P. | 2,209,615 6.680% | -388,121![]() (-14.94%) | Filing History |
| 2025-02-12 09:34 am Sale | 2024-12-31 | 13G | UROGEN PHARMA LTD URGN | Adage Capital Management, L.P. | 2,928,086 6.940% | -807,655![]() (-21.62%) | Filing History |
| 2025-02-12 09:33 am Purchase | 2024-12-31 | 13G | DYNAMIX CORP USD DYNC | Adage Capital Management, L.P. | 1,350,000 8.130% | 1,350,000![]() (New Position) | Filing History |
| 2025-02-12 09:33 am Purchase | 2024-12-31 | 13G | EYEPOINT INC EYPT | Adage Capital Management, L.P. | 5,750,000 8.420% | 1,958,580![]() (+51.66%) | Filing History |
| 2025-02-12 09:32 am Purchase | 2024-12-31 | 13G | ALIGOS THERAPEUTICS INC NE ALGS | Adage Capital Management, L.P. | 325,000 9.380% | 106,187![]() (+48.53%) | Filing History |

